Elio
Carbon footprint data for pharma chemicals missing from leading LCA databases, delivered in hours.
Browse related lists
Related on Causeartist
- Investors
Elio produces life cycle assessment (LCA) data for chemicals used in pharmaceutical synthesis. Its focus is carbon footprints. Most reagents, catalysts, ligands, and API building blocks have no dataset in leading LCA databases. Elio aims to fill that gap, which it calls the missing 99.995%.
The company uses conventional LCA methods that follow ISO 14067, TfS, and PAS 2090. Every value is grounded in a documented source. Elio states its data is never AI-generated. Results arrive in hours. The approach scales to tens of thousands of compounds. Elio also offers an ecodesign app and publishes its method and research.
Elio serves pharma teams that need footprints for the specific chemicals in their synthesis routes. Companies can submit a chemical list for a free, non-binding check. Lists stay confidential. Elio says its results fall within the error margin of leading LCA databases.
Key benefits
Fills data gaps
Covers reagents, catalysts, and building blocks that leading LCA databases lack.
Standards-aligned methods
Footprints follow ISO 14067, TfS, and PAS 2090.
Source-documented values
Every value traces to a documented source and is never AI-generated.
Pharma companies cannot reduce emissions they cannot measure. Most chemicals in drug synthesis lack carbon footprint data in standard LCA databases. Elio supplies source-documented footprints for these compounds. This lets R&D and sustainability teams compare routes and reagents and factor carbon into chemistry decisions earlier.
LCAs follow ISO 14067, TfS, and PAS 2090; results stated to fall within the error margin of leading LCA databases; every value grounded in a documented source, not AI-generated; results delivered in hours; scalable to tens of thousands of compounds
Investors
Frequently asked questions
- What does Elio do?
- Elio produces life cycle assessment (LCA) data for chemicals used in pharmaceutical synthesis. Its focus is carbon footprints. Most reagents, catalysts, ligands, and API building blocks have no dataset in leading LCA databases. Elio aims to fill that gap, which it calls the missing 99.995%. The company uses conventional LCA methods that follow ISO 14067, TfS, and PAS 2090. Every value is groun…
- Where is Elio based?
- Elio is based in Austria.
- What sector does Elio operate in?
- Elio operates in the AI & Technology sector.
- Who has invested in Elio?
- Published funders on Causeartist include Cerulean Ventures.
At a glance
Focus areas
Locations
- Investors
- 1
